Aachen papers per year

Papers 116

Minimal residual disease assessment following CD19‐targeted therapy in B‐cell precursor acute lymphoblastic leukemia using standardized 12‐color flow cytometry: A EuroFlow study
2025 HemaSphere article Medicine Acute Lymphoblastic Leukemia research Open access

Martijn W. C. Verbeek, Michaela Reiterová, Anna Laqua, Łukasz Sędek, Chiara Buracchi, Malicorne Buysse, +19 more

6

citations
Inhibiting the alarmin‐driven hematopoiesis‐stromal cell crosstalk in primary myelofibrosis ameliorates bone marrow fibrosis
2025 HemaSphere article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

Hélène F.E. Gleitz, Stijn N. R. Fuchs, Inge Snoeren, Charlotte Boys, James Shiniti Nagai, Hector Tejeda Mora, +11 more

5

citations
S183: PHASE III RANDOMIZED, MULTICENTER, OPEN-LABEL COMMODORE 1 TRIAL: COMPARISON OF CROVALIMAB VS ECULIZUMAB IN COMPLEMENT INHIBITOR-EXPERIENCED PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH)
2023 HemaSphere article Immunology and Microbiology Complement system in diseases Open access

Phillip Scheinberg, Diego V. Clé, Valentina Giai, Marek Hus, Jin Seok Kim, Cristina Barrenetxea Lekue, +11 more

5

citations
Summary of Joint European Hematology Association (EHA) and EuroBloodNet Recommendations on Diagnosis and Treatment of Methemoglobinemia
2021 HemaSphere article Medicine Methemoglobinemia and Tumor Lysis Syndrome Open access

Elisa Fermo, Stefano Ghirardello, Patrick G. Gallagher, Razan Mohty, Mariane de Montalembert

5

citations
Experience With IVDR Implementation in Three Diagnostic Laboratories: Messages to EU Health Institutions, Diagnostic Healthcare Payers, and Authorities
2023 HemaSphere article Health Professions Healthcare Regulation Open access

Bart R. Lubbers, Isabel Dombrink, Tomáš Kalina, Mattias Hofmans, Morten Sichlau Bruun, Simon J. Stanworth, +5 more

5

citations
The EHA Research Roadmap: Blood Coagulation and Hemostatic Disorders
2021 HemaSphere article Medicine Blood Coagulation and Thrombosis Mechanisms Open access

Sabine Eichinger, Pierre‐Emmanuel Morange, Marco Cattaneo, Mathilde Frétigny, Antoine Rauch, Astrid van Hylckama Vlieg, +8 more

5

citations
Immune‐based Therapies for Hematological Malignancies: An Update by the EHA SWG on Immunotherapy of Hematological Malignancies
2020 HemaSphere article Medicine Cancer Immunotherapy and Biomarkers Open access

Hermann Einsele, Javier Briones, Fabio Ciceri, Irene García‐Cadenas, Fred Falkenburg, Natacha Bolaños, +10 more

5

citations
Influence of Telomere Length on the Achievement of Deep Molecular Response With Imatinib in Chronic Myeloid Leukemia Patients
2021 HemaSphere article Medicine Chronic Myeloid Leukemia Treatments Open access

4

citations
P1023: AVAPRITINIB IN PATIENTS WITH ADVANCED SYSTEMIC MASTOCYTOSIS (ADVSM): EFFICACY AND SAFETY ANALYSES FROM THE PHASE 2 PATHFINDER STUDY WITH 2-YEAR FOLLOW-UP
2023 HemaSphere article Immunology and Microbiology Mast cells and histamine Open access

Jason R. Gotlib, Andreas Reiter, Deepti H. Radia, Michael W. Deininger, Tracy I. George, Jens Panse, +16 more

4

citations
Causes of death among patients diagnosed with chronic lymphocytic leukemia: A population‐based study in the Netherlands, 1996–2020
2024 HemaSphere article Medicine Chronic Lymphocytic Leukemia Research Open access

Lina van der Straten, Mark‐David Levin, Manette A. W. Dinnessen, Otto J. Visser, Eduardus F. M. Posthuma, Jeanette K. Doorduijn, +3 more

4

citations
Transcriptional profiling directs the classification of acute leukemias of ambiguous lineage into AML, B‐ALL, or T‐ALL
2025 HemaSphere article Medicine Acute Myeloid Leukemia Research Open access

Roger Mulet‐Lazaro, Anikó Sijs‐Szabó, Remco Michiel Hoogenboezem, Stanley van Herk, Carla Exalto, Jasper E. Koenders, +12 more

4

citations
P892: ANALYSIS OF INFECTIONS AND PARAMETERS OF HUMORAL IMMUNITY IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH TALQUETAMAB (TAL) MONOTHERAPY IN MONUMENTAL-1
2023 HemaSphere article Medicine Multiple Myeloma Research and Treatments Open access

Leo Rasche, Carolina Schinke, Ajai Chari, Brea C. Lipe, Noa Lavi, Paula Rodríguez‐Otero, +13 more

4

citations
P1399: INITIAL CLINICAL RESULTS OF EUPLAGIA-1, A PHASE 1/2 TRIAL OF POINT-OF-CARE MANUFACTURED GLPG5201 IN R/R CLL/SLL WITH OR WITHOUT RICHTER’S TRANSFORMATION
2023 HemaSphere article Medicine Chronic Lymphocytic Leukemia Research Open access

Núria Martínez‐Cibrián, Sergi Betriu, Valentín Ortiz‐Maldonado, Daniel Esteban, Natalia Tovar, Ana Triguero Moreno, +7 more

4

citations
The EHA Research Roadmap: Transfusion Medicine
2022 HemaSphere article Medicine Blood transfusion and management Open access

Srini V. Kaveri, Jagadeesh Bayry, Miloš Bohoněk, Andreas S. Buser, Jean‐Daniel Tissot, Ashley Mark Toye, +2 more

4

citations
Wnt‐dependent spatiotemporal reprogramming of bone marrow niches drives fibrosis
2026 HemaSphere article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access

Bella Banjanin, James Shiniti Nagai, YeVin Mun, Stijn N. R. Fuchs, Inge Snoeren, Joachim Boers, +28 more

3

citations
Impaired Overall Survival in Young Patients With Acute Myeloid Leukemia and Variants in Genes Predisposing for Myeloid Malignancies
2022 HemaSphere article Medicine Acute Myeloid Leukemia Research Open access

Martin Kirschner, Benjamin Rolles, Martina Margrit Crysandt, Christoph Röllig, Friedrich Stölzel, Michael Krämer, +13 more

3

citations
S125: 10-DAY DECITABINE VS. CONVENTIONAL CHEMOTHERAPY (“3 + 7”) FOLLOWED BY ALLOGRAFTING (HSCT) IN AML PATIENTS ≥60 YEARS: A RANDOMIZED PHASE III STUDY OF THE EORTC LEUKEMIA GROUP, GIMEMA, CELG, AND GMDS-SG
2022 HemaSphere article Medicine Acute Myeloid Leukemia Research Open access

M Lübbert, P. W. Wijermans, Michal Kiciński, Sylvain Chantepie, Walter J. F. M. van der Velden, Richard Noppeney, +26 more

3

citations
P930: ISATUXIMAB, LENALIDOMIDE, BORTEZOMIB AND DEXAMETHASONE AS INDUCTION THERAPY FOR NEWLY-DIAGNOSED MULTIPLE MYELOMA PATIENTS WITH HIGH-RISK CYTOGENETICS: A SUBGROUP ANALYSIS FROM THE GMMG-HD7 TRIAL
2022 HemaSphere article Medicine Multiple Myeloma Research and Treatments Open access

E. K. Mai, Uta Bertsch, R. Fenk, Diana Tichy, Britta Besemer, Jan Dürig, +27 more

3

citations
P774: SUBSTANTIAL INCREASES IN PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) RED BLOOD CELL CLONE SIZE WITH ORAL IPTACOPAN MONOTHERAPY CONFIRMS CONTROL OF HEMOLYSIS IN COMPLEMENT INHIBITOR-NAÏVE PNH PATIENTS
2023 HemaSphere article Immunology and Microbiology Complement system in diseases Open access

Régis Peffault de Latour, Bing Han, Jaroslaw Pawel Maciejewski, Yutaka Ueda, Rong Fu, Li Zhang, +15 more

3

citations
Primary Cancer Matters in Therapy-related Myeloid Neoplasm Patients Receiving Allogeneic Hematopoietic Cell Transplantation: A Study From the Chronic Malignancies Working Party of the EBMT
2023 HemaSphere article Medicine Multiple and Secondary Primary Cancers Open access

Marie Robin, Liesbeth C. de Wreede, Thomas A. Schroeder, Friedrich Stölzel, Nicolaus Kröger, Linda Köster, +18 more

3

citations

Most active Aachen authors

Tim H. Brümmendorf 16,145 citations overall
18 papers
Jens Panse 10,288 citations overall
14 papers
Steffen Koschmieder 11,677 citations overall
13 papers
Joost S.P. Vermaat 3,482 citations overall
10 papers
Fabian Beier 3,900 citations overall
9 papers
Susanne Isfort 2,466 citations overall
8 papers
Jacques J. M. van Dongen 55,067 citations overall
5 papers
Martina Margrit Crysandt 2,348 citations overall
5 papers
Ivan G. Costa 12,219 citations overall
4 papers
Edgar Jost 3,752 citations overall
4 papers
Deniz Gezer 1,428 citations overall
4 papers
Margherita Vieri 507 citations overall
4 papers
Rafael Kramann 16,535 citations overall
3 papers
James Shiniti Nagai 2,988 citations overall
3 papers
Nicolas Chatain 1,606 citations overall
3 papers

HemaSphere ▲ Sign in to save

Aachen papers per year

Papers 116

Most active Aachen authors

HemaSphere Sign in to save